Workflow
全球健康治理
icon
Search documents
聚集防治三大传染病,全球基金在南非G20峰会前筹资113亿美元
第一财经· 2025-11-25 16:02
2025.11. 25 本文字数:2269,阅读时长大约4分钟 作者 | 第一财经 钱小岩 封图 | 肯尼亚医疗用品管理局仓库内全球基金提供的医药品 (来源:受访者提供) 肯尼亚艾滋病患者服用的药品、印尼社区筛查肺结核的开支、塞内加尔农村防范蚊虫叮咬的蚊帐…… 这些看似分散的传染病防治工作背后,都不难发现同一个身影——抗击艾滋病、结核病和疟疾全球基 金(以下称"全球基金")。 二十国集团领导人峰会(G20峰会)11月22日至23日在南非约翰内斯堡举行,这是G20峰会首次在 非洲大陆举办,具有重要历史意义。非洲是艾滋病、结核病和疟疾这三大传染病负担最重的大陆。在 本次G20峰会召开前一天的21日,全球基金在约翰内斯堡举行了第八次增资大会,为未来三年筹措 资金。 自2002年成立以来,中国与全球基金的关系经历了从受援国到捐助国和治理伙伴的转变。全球基金 传播事务负责人费格(Christy Feig)日前在清华大学举办的第四届全球发展与健康传播论坛对第一 财经记者表示,中国可以在非洲健康问题上发挥更为关键的作用,无论是在技术输出、知识转让还是 药品生产方面,中国都具备显著的优势。 她还特别强调道,更重要的是非洲伙伴 ...
聚集防治三大传染病,全球基金在南非G20峰会前筹资113亿美元
Di Yi Cai Jing· 2025-11-25 08:01
二十国集团领导人峰会(G20峰会)11月22日至23日在南非约翰内斯堡举行,这是G20峰会首次在非洲 大陆举办,具有重要历史意义。非洲是艾滋病、结核病和疟疾这三大传染病负担最重的大陆。在本次 G20峰会召开前一天的21日,全球基金在约翰内斯堡举行了第八次增资大会,为未来三年筹措资金。 自2002年成立以来,中国与全球基金的关系经历了从受援国到捐助国和治理伙伴的转变。全球基金传播 事务负责人费格(Christy Feig)日前在清华大学举办的第四届全球发展与健康传播论坛对第一财经记者 表示,中国可以在非洲健康问题上发挥更为关键的作用,无论是在技术输出、知识转让还是药品生产方 面,中国都具备显著的优势。 她还特别强调道,更重要的是非洲伙伴对中国始终保持着高度信任,"这种优势互补,更加增强了合作 的成效。" 目前因艾滋病、结核病和疟疾死亡的人数较二十年前已至少减少一半。 肯尼亚艾滋病患者服用的药品、印尼社区筛查肺结核的开支、塞内加尔农村防范蚊虫叮咬的蚊帐……这 些看似分散的传染病防治工作背后,都不难发现同一个身影——抗击艾滋病、结核病和疟疾全球基金 (以下称"全球基金")。 除国家捐助方外,还有很多私有基金会参与捐 ...
中英医疗科创高峰论坛成功举办 BMJ推动全球医学创新协同发展
Huan Qiu Wang· 2025-09-17 08:12
Core Viewpoint - The 2025 Capital International Medical Conference emphasizes the importance of international collaboration in medical technology innovation, particularly between China and the UK, to enhance global health governance and address common health challenges [3][4][6]. Group 1: Conference Highlights - The conference was attended by over 1,500 leaders and experts, showcasing the commitment to advancing medical technology and health research [1]. - Keynote speeches included a presentation by Kamran Abassi, editor of the British Medical Journal, focusing on deepening Sino-British medical technology cooperation [3][4]. - The conference featured the release of the "2025 China Hospital Research Impact Report," which analyzes the citation of Chinese hospital research in global health policies and clinical guidelines over the past 20 years [5][6]. Group 2: Report Insights - The report covers the period from 2005 to 2024 and evaluates how research from selected hospitals translates into real-world impacts, highlighting the contributions of Chinese hospitals to global health policy [5][6]. - A total of 12,601 research outputs from Chinese hospitals were cited in health policies and clinical guidelines across over 75 countries, with a total citation count of 34,675 [5]. - The report underscores the growing international influence of Chinese medical research in shaping healthcare standards and improving patient outcomes globally [6]. Group 3: Collaborative Opportunities - The Sino-British Medical Technology Innovation Forum gathered policymakers, hospital managers, and medical researchers to discuss opportunities for collaboration in addressing shared healthcare challenges [7][8]. - Experts discussed the importance of data-driven approaches and the role of artificial intelligence in advancing medical innovation, while also acknowledging the challenges that lie ahead [8][9]. - The conference initiated a competition for innovative medical technology projects, aiming to foster an open and collaborative ecosystem for medical innovation in China [9].
综述|第78届世界卫生大会取得关键成果 推进全球健康议程
Xin Hua Wang· 2025-05-28 16:30
Group 1 - The 78th World Health Assembly concluded with key resolutions aimed at strengthening global health systems and response capabilities [1][2] - The assembly approved the significant "Pandemic Accord," which is a result of over three years of negotiations among countries to enhance global cooperation for future pandemics [1][2] - The World Health Organization's (WHO) budget for 2026-2027 was set at $4.2 billion, reduced from the initially proposed $5.3 billion, with a 20% increase in assessed contributions from member states [2] Group 2 - The assembly addressed various global health issues, including rare diseases, climate change and health, and antimicrobial resistance [3] - A resolution on rare diseases was passed to accelerate actions addressing the diagnostic delays and inadequate treatment faced by over 300 million patients globally [3] - The assembly approved a draft global action plan on climate change and health, setting new action goals for member states and the WHO in this area [3]